indianstockmarket
Home Results Stocks to Buy About Us Contact Us
 
indianstockmarket
 
ABB Limited
ACC Limited
Bajaj Auto Ltd
Bharti Airtel Limited
Bharat Heavy Electricals Ltd
Cipla Ltd
Dabur India Ltd
Dr. Reddy's Laboratories
GAIL (India) Limited
GlaxoSmithKline Ltd
Grasim Industries Ltd
Gujarat Ambuja Cement Ltd
HCL Technologies Ltd
H D F C
HDFC Bank Ltd
Hero Honda Motors Ltd
Hindalco Industries Ltd
Hindustan Lever Ltd
H P C L
ICICI Bank Ltd
Infosys Technologies Ltd
I P C L
I T C Ltd
Jet Airways (India) Ltd
Larsen & Toubro Limited
Mahindra & Mahindra Ltd
Maruti Udyog Limited
M T N L
N A L C O
Oil & Natural Gas Corpn Ltd
Oriental Bank of Commerce
Punjab National Bank
Ranbaxy Laboratories Ltd
Reliance Communications
Reliance Energy Ltd
Reliance Industries Ltd
Steel Authority of India Ltd
Satyam Computer Services
State Bank of India
Siemens Ltd
Sun Pharmaceuticals
Suzlon Energy Ltd
Tata Motors Limited
Tata Power Co. Ltd
Tata Steel Limited
Tata Consultancy Services
V S N L
Wipro Ltd
Zee Telefilms Ltd
Mutual Funds
 
http://mumbaibull.com
 
http://winfromus.com
 

Indian Stock Market

Indianstockmarket.net is an effort to educate indian investor by providing useful stock news, stock market websites, informative articles, resources to various investment guides.
Yahoo   Google
Tue, 31 Aug 2010 23:42:31 -0700

GSK, Valeant Pharma say US FDA extends PDUFA goal date for ezogabine
GlaxoSmithKline and Valeant Pharmaceuticals International announced the US Food and Drug Administration (FDA) has extended the Prescription Drug User Fee Act (PDUFA) goal date for ezogabine to November 30, 2010. The original goal date was August 30, 2010.
Mon, 30 Aug 2010 10:33:14 -0700

Study finds first genetic link to common migraine
Agencies London, Aug 30: An international scientific team has identified for the first time a genetic risk factor associated with common migraines and say their research could open the way for new treatments to prevent migraine attacks.
Wed, 25 Aug 2010 21:42:30 -0700

EC grants marketing authorisation to amend the licence of GSK's cervical cancer vaccine, Cervarix
GlaxoSmithKline (GSK) confirmed that the European Commission has granted marketing authorisation to amend the licence for its cervical cancer vaccine, Cervarix.
Sat, 28 Aug 2010 00:55:10 -0700

Swine flu jab under scrutiny over dangerous sleep disorder fears
London, Aug 28 : A swine flu vaccine given to millions of Britons is undergoing investigations over fear it causes a rare and dangerous sleep disorder.
Wed, 25 Aug 2010 22:53:28 -0700

Neural switch that controls fear discovered
Washington, Aug 26 : Researchers at the European Molecular Biology Laboratory (EMBL) in Monterotondo, Italy and GlaxoSmithKline in Verona, Italy, have discovered the neural switch that controls fear.
Tue, 24 Aug 2010 02:42:45 -0700

GSK begins phase III trials to develop herpes zoster vaccine for prevention of shingles
Copyright © Saffron Media Pvt. Ltd. Designed & Maintained by Fast Cursor
Mon, 23 Aug 2010 12:24:34 -0700

Foreign in pharma
The Union commerce ministry has reportedly initiated an exercise to determine if checks need to be placed on foreign investment in Indian drug firms (currently 100 per cent investment is allowed through the automatic route) in view of several acquisitions that have taken place in the last few years.
 
Fri, 03 Sep 2010 18:33:51 GMT+00:00


Abbott abandons plans to sell vaccines business
The Associated Press
Analysts speculated that European vaccine powerhouses such as GlaxoSmithKline PLC and Novartis AG would have been interested in the business. ...

and more »
Tue, 31 Aug 2010 00:46:05 GMT+00:00


ABC2 News

GlaxoSmithKline, Valeant Pharma Say U.S. FDA Extends Prescription Drug User ...
RTT News
(RTTNews) - Monday, GlaxoSmithKline (GSK) and Valeant Pharmaceuticals International (VRX: News ) said that the US Food and Drug Administration or FDA has ...
GlaxoSmithKline receives new FDA PDUFA goal date for ezogabineTrading Markets (press release)
Glaxo, Valeant face US delay for epilepsy drugBusinessWeek
FDA delays review of Glaxo-Valeant epilepsy drugBizjournals.com
North Carolina News Network -Drug Store News -Bloomberg
all 93 news articles »
Wed, 01 Sep 2010 13:21:40 GMT+00:00


Equity Research on GlaxoSmithKline and Abbott Laboratories - The Emerging ...
MarketWatch (press release)
Companies like GlaxoSmithKline plc and Abbott Laboratories are now expanding in South America, and Asia, particularly India, with positive results. ...

and more »
Thu, 19 Aug 2010 11:40:11 GMT+00:00


GlaxoSmithKline: FDA Priority Review Designation For Benlysta
Wall Street Journal
LONDON (Dow Jones)--GlaxoSmithKline PLC (GSK.LN) and Human Genome Sciences, Inc. (HGSI) announced Thursday that the US Food and Drug Administration or FDA ...
Potential lupus drug gets FDA priority reviewBusinessWeek
FDA to give review to HGS-Glaxo lupus treatment; Dollar Tree gains in 2nd quarterWashington Post
Glaxo, Human Genome get fast review for lupus drugReuters
Zenopa -Medical News Today -Pharma Times
all 85 news articles »
Fri, 03 Sep 2010 12:36:52 GMT+00:00


XenoPort Announces New Employment Inducement Award
MarketWatch (press release)
XenoPort is developing its lead product candidate in collaboration with Astellas Pharma Inc. and GlaxoSmithKline. XenoPort's product candidates are being ...

and more »
Fri, 03 Sep 2010 05:01:49 GMT+00:00


euroClinix

EMA reviews safety of GSK vaccine
Pharmaceutical Technology Magazine
The European Medicines Agency (EMA) has launched a review of GlaxoSmithKline's pandemic influenza vaccine Pandemrix to investigate whether there is a link ...
European Medicines Agency investigating PandemrixVaccineNewsDaily
Reports of narcolepsy in Europe following vaccination with Pandemrix™WebWire (press release)
Swine Flu Vaccine Tested Following Sleep Disorder FearseuroClinix

all 9 news articles »
Wed, 01 Sep 2010 19:50:50 GMT+00:00


GlaxoSmithKline's Shares Changing Hands at Higher Prices on 1.1x Above-Average ...
Benzinga
Shares of GlaxoSmithKline (NYSE: GSK) are trading up 3.6% to $38.74 today on above average volume. Approximately 2.1 million shares have traded hands today ...
GLAXOSMITHKLINE'S SHARES CHANGING HANDS AT HIGHER PRICES ON 1.1X ABOVE-AVERAGE ...Zacks.com

all 3 news articles »
 
Directory | Disclaimer
 
Developed by WorldITLab.
 
Copyright © 2004 - 2007 indianstockmarket.net . All rights reserved worldwide.
 
Content by Stock Market Guide